Pneumococcal vaccine after 15 years of use: Another view

Archives of Internal Medicine

Volumn 154, Issue 22, 1994, Pages 2531-2535

  Fedson, D S ^a   Shapiro, E D ^a   LaForce, F M ^a   Mufson, M A ^a   Musher, D M ^a   Spika, J S ^a   Breiman, R F ^a   Broome, C V ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PNEUMOCOCCUS VACCINE;

COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DRUG EFFICACY; HEALTH CARE COST; HUMAN; INFECTION PREVENTION; LOBAR PNEUMONIA; NOTE; PRIORITY JOURNAL; STREPTOCOCCUS INFECTION; UNITED STATES; VACCINATION;

AGE FACTORS; AGED; BACTERIAL VACCINES; CLINICAL TRIALS; HUMAN; IMMUNOCOMPROMISED HOST; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; RESEARCH DESIGN; STREPTOCOCCUS PNEUMONIAE;

EID: 0028051426     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.154.22.2531     Document Type: Note

References (0)